Skip to content

CyrOablatiOn for puLmonary vein isolation alone in patients with early PERsistent AF assessed by continuous monitoring

CyrOablatiOn for puLmonary vein isolation alone in patients with early PERsistent AF assessed by continuous monitoring

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005857
Enrollment
130
Registered
2021-02-03
Start date
2021-01-13
Completion date
Unknown
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age =20 years, <80 years (2) Drug refractory symptomatic persistent AF diagnosed within 3 years (3) Either two conditions 1) AF episode lasting longer than 7 days, but less than 3 years documented by consecutive ECG recordings of 100% AF greater than 7 days apart or 2) AF episode requiring electrical or pharmacological cardioversion after 24 hours of AF documented by continuous recording

Exclusion criteria

Exclusion criteria: (1) Long-standing persistent AF more than 3 years (2) Previous ablation procedure or surgery for AF (3) Contraindication to chronic anticoagulation therapy or heparin (4) Documented left atrial diameter >50 mm from parasternal long-axis view (5) A percutaneous coronary intervention or myocardial infarction =3 months (6) A stroke or transient ischemic attack =6 months (7) Planned cardiovascular intervention (8) Mental or physical inability to participate in the study (9) Participation in another randomized clinical trial (10) Uncontrolled hypertension, untreated hypothyroidism or hyperthyroidism (11) Requirement for dialysis due to terminal renal failure (12) Recurrent sinus rhythm after electrical cardioversion (13) Sinus rhythm at enrollment (14) Severe left ventricular dysfuncion (LV ejection fraction < 30%)

Design outcomes

Primary

MeasureTime frame
Change of ILR-detected AF/AT burden during the first year after PVI compared to pre-ablation AF/AT burden

Secondary

MeasureTime frame
Time to the first recurrence of AF/AT, lasting for 30 seconds or more;Recurrence nature of AF (paroxysmal or persistent);Symptoms of AF assessed with the use of the modified European Heart Rhythm Association symptom classification; range, 1 to 4;Quality of life assessed with the use of the Medical Outcomes Study 36-Item Short-From Health Survey [SF-36]

Countries

Korea, Republic of

Contacts

Public ContactJihee Min

Seoul National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026